Neumann Bernhard, Hierl Andreas, Wunderlich Silke, Meier Helen, Bauer Christina, Gerner Stefan T, Rieder Georg, Geis Tobias, Kunkel Jürgen, Bauswein Markus, Niller Hans Helmut, Schmidt Barbara, Rubbenstroth Dennis, Beer Martin, Linker Ralf A, Jantsch Jonathan, Angstwurm Klemens
Department of Neurology, University of Regensburg, Bezirksklinikum Regensburg, Regensburg, Germany; Department of Neurology, Donau-Isar-Klinikum Deggendorf, Deggendorf, Germany.
Department of Neurology, University of Regensburg, Bezirksklinikum Regensburg, Regensburg, Germany.
J Neurol Sci. 2023 Mar 15;446:120568. doi: 10.1016/j.jns.2023.120568. Epub 2023 Jan 25.
Borna disease virus 1 (BoDV-1) has been recognized as a rare cause of very severe encephalitis with rapid onset in central Europe. Data on cerebrospinal fluid (CSF) analysis have not yet been analyzed in detail. Here, we present the first study on CSF changes in BoDV-1 encephalitis. We retrospectively analyzed CSFs from 18 BoDV-1 encephalitis cases from Bavaria, Germany, an endemic region, from 1996 to 2021. Data were obtained through review of medical records and institutional databases. We found that white blood cell count (WBC) in CSF is elevated in 13 of our 18 patients at first examination (average 83.2 ± 142.3 leukocytes/μl) and cytology showed predominance of lymphocytes. Patients with typical symptoms of meningoencephalitis had higher WBC in first CSF analyzation (133.5 ± 163.1 vs 4.0 ± 3.2/μl; p = 0.065). BoDV-1 PCR of CSF is not always positive when tested (7 of 9 cases). Four of five patients tested showed a polyvalent reaction against multiple viruses in the CSF suggesting that BoDV-1 may trigger autoimmune mechanisms. CSF changes in BoDV-1 encephalitis seem similar to those of other viral encephalitis and at the beginning WBC can be normal in up to 28%, making the diagnosis even more challenging. All in all, BoDV-1 should be included in the diagnostic workup of patients with rapidly evolving and/or severe encephalitis and patients with severe neuropathy and secondary encephalopathy with and without CSF changes. Repeated CSF examinations as well as BoDV-1 serology and CSF PCR have to be considered in endemic areas.
博尔纳病病毒1型(BoDV-1)已被确认为中欧地区一种罕见的、可导致快速发病的极严重脑炎的病因。关于脑脊液(CSF)分析的数据尚未得到详细分析。在此,我们展示了第一项关于BoBoBoDV-1脑炎脑脊液变化的研究。我们回顾性分析了1996年至2021年来自德国巴伐利亚州(一个流行地区)的18例BoDV-1脑炎病例的脑脊液。数据通过查阅病历和机构数据库获得。我们发现,在首次检查时,18例患者中有13例脑脊液中的白细胞计数(WBC)升高(平均83.2±142.3个白细胞/微升),细胞学检查显示淋巴细胞占优势。具有脑膜脑炎典型症状的患者在首次脑脊液分析时白细胞计数更高(133.5±163.1 vs 4.0±3.2/微升;p = 0.065)。脑脊液的BoDV-1聚合酶链反应(PCR)检测时并非总是呈阳性(9例中有7例)。检测的5例患者中有4例显示脑脊液对多种病毒有多种反应,这表明BoDV-1可能触发自身免疫机制。BoDV-1脑炎的脑脊液变化似乎与其他病毒性脑炎相似,开始时白细胞计数高达28%可能正常,这使得诊断更具挑战性。总而言之,对于快速进展和/或严重脑炎患者以及伴有或不伴有脑脊液变化的严重神经病和继发性脑病患者,在诊断检查中应考虑BoDV-1。在流行地区,必须考虑重复进行脑脊液检查以及BoDV-1血清学和脑脊液PCR检测。